Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-06
2010-06-01
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S261000
Reexamination Certificate
active
07728014
ABSTRACT:
A novel compound having agonist activity at the S1P3receptor which is represented by the formula IwhereinX is selected from the group consisting of CR3, N and NO;Y is selected from the group consisting of CR3, N and NO;Z is selected from the group consisting of CR3, N and NO;and at least one of X, Y and Z is N or NO;V is O or NOR4R1is an aryl group;R2is an aryl group;R3is selected from the group consisting of H and alkyl; and 2 of said R3groups may together form a cyclic alkyl ring having from 3 to 6 carbon atoms;R4is selected from the group consisting of H and alkyl;a is 0 or an integer of from 1 to 6;b is 0 or 1;c is 0 or 1;f is 0 or an integer of 1 or 2;x is 0 or 1;y is 0 or an integer of from 1 to 3; andz is 0 or an integer of from 1 to 3.
REFERENCES:
patent: 6509469 (2003-01-01), Shintou et al.
patent: 7271266 (2007-09-01), Finke et al.
patent: WO-03/084930 (2003-10-01), None
patent: WO2005/058848 (2005-06-01), None
Hughes et al., Journal of American Chemical Society, 127(44), 15644-15651 and supplements S1-S138.
Gilchrist et al., Tetrahedron, 49(24), 5277-5290, 1993; CA 120: 106940, 1994.
Dittmar et al., Tetrahedron Letters, 59, 5171-5174, 1969; CA 72: 78841, 1970.
Francisco Palacios, et al., “Synthesis and Reactivity of Imines Derived from Bisphosphonates and 3-Phosphorylated 2-Aza-1,3-dienes,” Tetrahedron vol. 56, No. 34 (2000), pp. 6319-6330.
Domitila Aparicio, et al., “straightforward Access to Pyrazines, Piperazinones, and Oquinoxalines by Reactions of 1,2-Diaza-1,3-butadienes with 1,2-Diamines under Solution, Solvent-Free, or Solid-Phase Conditions,” J. Org. Chem. 2006, 71, pp. 5897-5905, XP-002466429.
Database Beilstein, XP002466430, 1995.
Database Beilstein, XP002466431, 1995.
Database Beilstein, XP002466432, 1955.
Database Beilstein, XP002466433, 1981.
Database Beilstein, XP002466434, 1956.
Database Beilstein, XP002466435, 2002.
Database accession No. 602026 Beilstein, XP002495008, 2004.
Database accession No. 2436778 Beilstein, XP002495009, 2002.
Database accession No. 4818030 Beilstein, XP002495010, 2005.
Database accession No. 2532400 Beilstein, XP002495011, 1977.
Database accession No. 4223051 Beilstein, XP002495012, 2005.
Database accession No. 2528516 Beilstein, XP002495013, 1977.
Database accession No. 602032 Beilstein, XP002495014, 1977.
Beard Richard L.
Donello John E.
Liu Xiaoxia
Yuan Haiqing
Allergan Inc.
Allergan, Inc.
Balasubramanian Venkataraman
Forrestal Kevin J.
Wurst John E.
LandOfFree
Heteroaromatic compounds having sphingosine-1-phosphate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaromatic compounds having sphingosine-1-phosphate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaromatic compounds having sphingosine-1-phosphate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4190552